1 |
ADRA1D
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D00680
D00680
|
Methylergometrine
| 3件: 118 118, 280, 288 |
2 |
ADRA1D
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D08207
D08207
|
Methylergometrine
| 3件: 118 118, 280, 288 |
3 |
ADRA1B
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D00680
D00680
|
Methylergometrine
| 3件: 118 118, 280, 288 |
4 |
ADRA1B
| 6件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D08207
D08207
|
Methylergometrine
| 3件: 118 118, 280, 288 |
5 |
ADRA1A
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D00680
D00680
|
Methylergometrine
| 3件: 118 118, 280, 288 |
6 |
ADRA1A
| 7件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | D08207
D08207
|
Methylergometrine
| 3件: 118 118, 280, 288 |
7 |
ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00680
D00680
|
Methylergometrine
| 3件: 118 118, 280, 288 |
8 |
ADRA2A
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08207
D08207
|
Methylergometrine
| 3件: 118 118, 280, 288 |
9 |
ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00680
D00680
|
Methylergometrine
| 3件: 118 118, 280, 288 |
10 |
ADRA2B
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08207
D08207
|
Methylergometrine
| 3件: 118 118, 280, 288 |
11 |
ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D00680
D00680
|
Methylergometrine
| 3件: 118 118, 280, 288 |
12 |
ADRA2C
| 2件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | D08207
D08207
|
Methylergometrine
| 3件: 118 118, 280, 288 |
13 |
F8
| 1件: Complement and coagulation cascades Complement and coagulation cascades | D00291
D00291
|
Desmopressin
| 1件: 288 288 |
14 |
F8
| 1件: Complement and coagulation cascades Complement and coagulation cascades | D02235
D02235
|
Desmopressin
| 1件: 288 288 |
15 |
F9
| 1件: Complement and coagulation cascades Complement and coagulation cascades | D10821
D10821
|
Emicizumab
| 1件: 288 288 |
16 |
F10
| 1件: Complement and coagulation cascades Complement and coagulation cascades | D10821
D10821
|
Emicizumab
| 1件: 288 288 |
17 |
NR3C1
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | D00473
D00473
|
Prednisone
| 4件: 288 288, 299, 300, 331 |
18 |
SERPIND1
| 1件: Complement and coagulation cascades Complement and coagulation cascades | D08547
D08547
|
Sulodexide
| 1件: 288 288 |
19 |
HMGCR
| 4件: Terpenoid backbone biosynthesis Terpenoid backbone biosynthesis, Metabolic pathways, AMPK signaling pathway, Bile secretion | D00434
D00434
|
Simvastatin
| 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
20 |
IL11RA
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Hematopoietic cell lineage | D05266
D05266
|
Oprelvekin
| 2件: 96 96, 288 |
21 |
SERPINC1
| 1件: Complement and coagulation cascades Complement and coagulation cascades | D08547
D08547
|
Sulodexide
| 1件: 288 288 |
22 |
PLG
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A | D01136
D01136
|
Tranexamic acid
| 6件: 46 46, 70, 215, 227, 288, 299 |
23 |
AVPR2
| 3件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption | D00291
D00291
|
Desmopressin
| 6件: 6 6, 64, 72, 75, 225, 288 |
24 |
AVPR2
| 3件: Phospholipase D signaling pathway Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption | D02235
D02235
|
Desmopressin
| 6件: 6 6, 64, 72, 75, 225, 288 |
25 |
PSMB5
| 8件: Proteasome Proteasome, Alzheimer disease, Parkinson disease, Amyotrophic lateral sclerosis, Huntington disease, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases | D03150
D03150
|
Bortezomib
| 16件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 228, 256, 283, 288, 331 |
26 |
MS4A1
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage | D02994
D02994
|
Rituximab
| 4件: 288 288, 296, 300, 331 |